Mainz Biomed N V
13F holders, Q3 2024 (September 30)11holders +2
4new positions
1sold out
$0.25avg. 13F price*
At the end of Q3 2024, 11 institutions reported holding Mainz Biomed N V in their 13F filings, up 2 from Q2 2024. 4 opened new positions and 1 sold out. The largest holders were Vontobel Holding Ltd. ($11K), Northern Trust Corp. ($7K) and Steward Partners Investment Advisory, LLC ($7K).
- Company
- Mainz Biomed N V
- CUSIP
- N5436L101
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $17K |
| Exits | 1 | $40 |
All 13F filers, Q2 2024 → Q3 2024: 89,519 shares bought and 100 shares sold, net +89,419 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Vontobel Holding Ltd. | 0.00% | Add +80.0% | 45,000 | $11K |
| Northern Trust Corp. | 0.00% | No change | 29,934 | $7K |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 29,000 | $7K |
| Two Sigma Securities, LLC | 0.00% | New | 23,515 | $6K |
| Geode Capital Management, LLC | 0.00% | No change | 15,189 | $4K |
| Jane Street Group, LLC | 0.00% | New | 14,559 | $4K |
| XTX Topco Ltd | 0.00% | Add +5.2% | 11,953 | $3K |
| Wealth Quarterback LLC | 0.00% | No change | 10,000 | $2K |
| FMR LLC | 0.00% | New | 1,850 | $461 |
| Citigroup Inc. | 0.00% | No change | 673 | $168 |
| Morgan Stanley | 0.00% | No change | 200 | $50 |
"% of holder's portfolio" is MAINZ BIOMED N V's weight in each manager's 13F, not the share of Mainz Biomed N V the manager owns.